Literature DB >> 21656395

Clinician knowledge about use of intrauterine devices in adolescents in South Carolina AHEC.

Vanessa A Diaz1, Nikki Hughes, Lori M Dickerson, Andrea M Wessell, Peter J Carek.   

Abstract

BACKGROUND AND OBJECTIVES: Intrauterine devices (IUDs) are recommended as first-line choices for both nulliparous and parous adolescents by the American College of Obstetrics and Gynecology (ACOG). This study describes use of IUDs and knowledge regarding IUD use in adolescents in South Carolina family medicine residency programs.
METHODS: Faculty and residents in South Carolina Area Health Education Consortium (SC AHEC) Family Medicine Residency Programs received an anonymous survey including questions about current use of IUDs and scenarios where they were asked whether they would recommend an IUD. Proportions were compared using chi-square or Fisher's Exact Test. Modified Wald method was utilized to calculate 95% confidence intervals.
RESULTS: The survey response rate was 53.8% (n=133). Most respondents (78%) prescribed IUDs and 42% inserted them, but ≥ 90% reported only prescribing or inserting ≤ 10 yearly. In scenarios where IUD recommendation was appropriate, only 27% (95% CI: 20.2-35.2) recommended IUDs for a sexually active adolescent, whereas 60% (95% CI: 51.7-68.1) recommended use for a postpartum adolescent. For similar scenarios in non-adolescents, a statistically significant higher proportion recommended IUDs, with 50% (95% CI: 42.0-58.7) recommending use in a 21-year-old nulliparous woman and 77% (95% CI: 68.8-83.1) in a breast-feeding mother. Women were more likely to recommend IUD use than men in non-adolescents, but not adolescents. There was no difference in recommendations by level of training.
CONCLUSIONS: Knowledge regarding IUD use in nulliparous women and adolescents is limited in this sample of family physicians. Increasing appropriate IUD recommendations may increase IUD use and improve contraceptive counseling for adolescents.

Entities:  

Mesh:

Year:  2011        PMID: 21656395

Source DB:  PubMed          Journal:  Fam Med        ISSN: 0742-3225            Impact factor:   1.756


  7 in total

1.  The Use of ACOG Guidelines: Perceived Contraindications to IUD and Implant Use Among Family Planning Providers.

Authors:  Ash E Philliber; Heather Hirsch; Claire D Brindis; Rita Turner; Susan Philliber
Journal:  Matern Child Health J       Date:  2017-09

2.  Louisiana and Mississippi Family Physicians' Contraception Counseling for Adolescents with a Focus on Intrauterine Contraception.

Authors:  Susan E Rubin; Lauren N Coy; Qingzhao Yu; Herbert L Muncie
Journal:  J Pediatr Adolesc Gynecol       Date:  2016-02-10       Impact factor: 1.814

3.  Determinants of Long-acting Reversible Contraception (LARC) Initial and Continued Use among Adolescents in the United States.

Authors:  C Emily Hendrick; Joshua N Cone; Jessica Cirullo; Julie Maslowsky
Journal:  Adolesc Res Rev       Date:  2019-07-12

4.  Intrauterine devices at six months: does patient age matter? Results from an urban family medicine federally qualified health center (FQHC) network.

Authors:  Anita Ravi; Linda Prine; Eve Waltermaurer; Natasha Miller; Susan E Rubin
Journal:  J Am Board Fam Med       Date:  2014 Nov-Dec       Impact factor: 2.657

Review 5.  Provider and lay perspectives on intra-uterine contraception: a global review.

Authors:  Marina A S Daniele; John Cleland; Lenka Benova; Moazzam Ali
Journal:  Reprod Health       Date:  2017-09-26       Impact factor: 3.223

6.  Exploring the Uptake of Long-Acting Reversible Contraception in South Dakota Women and the Importance of Provider Education.

Authors:  Tess L Weber; Ashley Briggs; Jessica D Hanson
Journal:  S D Med       Date:  2017-11

7.  Long-Acting Reversible Contraception: Placement, Continuation, and Removal Rates at an Inner-City Academic Medical Center Clinic.

Authors:  Aliye Runyan; Robert A Welch; Katherine J Kramer; Sarah Cortez; LeAnne J Roberts; Clementina Asamoah; Sarah Ottum; Jessica Sanders; Adib Shafi; Maurice-Andre Recanati
Journal:  J Clin Med       Date:  2021-04-28       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.